Lupin joins those settling with Sunovion over Lunesta
This article was originally published in Scrip
Executive Summary
Lupin expects to launch its generic version of Sepracor's (now Sunovion Pharmaceuticals) insomnia treatment, Lunesta (eszopiclone) tablets, in the US on 30 November 2013, as part of a settlement between the two companies over patent litigation concerning the product.